Charles River Laboratories International, Inc. Stock News

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at UBS and Jefferies Conferences.

Charles River Laboratories International, Inc. (NYSE:CRL ) Q3 2024 Earnings Conference Call November 6, 2024 9:30 AM ET Company Participants Todd Spencer - Corporate Vice President of Investor Relations James Foster - President and Chief Executive Officer Flavia Pease - Chief Financial Officer Conference Call Participants Max Smock - William Blair & Company Matthew Sykes - Goldman Sachs David W...

Donald Trump's return to the White House is making big winners out of some S&P 500 stocks. The post 12 Stocks Win Big From Trump's White House Victory appeared first on Investor's Business Daily.

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients for its drug discovery and development services.

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories issues its third-quarter 2024 financial results.

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River launches the Retrogenix® Non-Human Protein Library to support assessment of off-target binding, de-risk studies & aid model selection.

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories schedules third-quarter 2024 earnings release and conference call.

BOSTON--(BUSINESS WIRE)--Banorte is now live on Charles River's cloud-based Investment Management Solution.